- Home
- ENSC vs SOAR Comparison
ENSC vs SOAR Comparison
Compare ENSC & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- SOAR
- Stock Information
- Founded
- ENSC 2003
- SOAR 2021
- Country
- ENSC United States
- SOAR United States
- Employees
- ENSC N/A
- SOAR N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- SOAR Blank Checks
- Sector
- ENSC Health Care
- SOAR Finance
- Exchange
- ENSC Nasdaq
- SOAR Nasdaq
- Market Cap
- ENSC 9.0M
- SOAR 9.3M
- IPO Year
- ENSC N/A
- SOAR N/A
- Fundamental
- Price
- ENSC $6.45
- SOAR $0.18
- Analyst Decision
- ENSC
- SOAR
- Analyst Count
- ENSC 0
- SOAR 0
- Target Price
- ENSC N/A
- SOAR N/A
- AVG Volume (30 Days)
- ENSC 63.3K
- SOAR 1.2M
- Earning Date
- ENSC 03-14-2025
- SOAR 03-25-2025
- Dividend Yield
- ENSC N/A
- SOAR N/A
- EPS Growth
- ENSC N/A
- SOAR N/A
- EPS
- ENSC N/A
- SOAR N/A
- Revenue
- ENSC $4,421,404.00
- SOAR $102,271,000.00
- Revenue This Year
- ENSC $89.78
- SOAR N/A
- Revenue Next Year
- ENSC N/A
- SOAR N/A
- P/E Ratio
- ENSC N/A
- SOAR N/A
- Revenue Growth
- ENSC 40.41
- SOAR 97.25
- 52 Week Low
- ENSC $2.12
- SOAR $0.16
- 52 Week High
- ENSC $22.47
- SOAR $4.50
- Technical
- Relative Strength Index (RSI)
- ENSC 39.92
- SOAR 36.52
- Support Level
- ENSC $6.61
- SOAR $0.16
- Resistance Level
- ENSC $7.36
- SOAR $0.21
- Average True Range (ATR)
- ENSC 0.65
- SOAR 0.02
- MACD
- ENSC -0.13
- SOAR -0.00
- Stochastic Oscillator
- ENSC 6.32
- SOAR 23.46
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.